In the BioHarmony Drug Report Database

"Preview" Icon

Anakinra

Kineret (anakinra) is a protein pharmaceutical. Anakinra was first approved as Kineret on 2001-11-14. It is used to treat cryopyrin-associated periodic syndromes and rheumatoid arthritis in the USA. It has been approved in Europe to treat rheumatoid arthritis. The pharmaceutical is active against interleukin-1 receptor type 1.

 

Trade Name

 

Kineret
 

Common Name

 

anakinra
 

ChEMBL ID

 

CHEMBL1201570
 

Indication

 

cryopyrin-associated periodic syndromes, rheumatoid arthritis
 

Drug Class

 

Interleukin-1 (IL-1) receptor antagonists

Image (chem structure or protein)

Anakinra structure rendering